These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26647387)

  • 1. System-L amino acid transporters play a key role in pancreatic β-cell signalling and function.
    Cheng Q; Beltran VD; Chan SM; Brown JR; Bevington A; Herbert TP
    J Mol Endocrinol; 2016 Apr; 56(3):175-87. PubMed ID: 26647387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells.
    Rosario FJ; Kanai Y; Powell TL; Jansson T
    J Physiol; 2013 Feb; 591(3):609-25. PubMed ID: 23165769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relations of leucine derivatives reveal critical moieties for cellular uptake and activation of mTORC1-mediated signaling.
    Nagamori S; Wiriyasermkul P; Okuda S; Kojima N; Hari Y; Kiyonaka S; Mori Y; Tominaga H; Ohgaki R; Kanai Y
    Amino Acids; 2016 Apr; 48(4):1045-1058. PubMed ID: 26724922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice.
    Bermudez-Silva FJ; Romero-Zerbo SY; Haissaguerre M; Ruz-Maldonado I; Lhamyani S; El Bekay R; Tabarin A; Marsicano G; Cota D
    Dis Model Mech; 2016 Jan; 9(1):51-61. PubMed ID: 26563389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular signaling of amino acids towards mTORC1 activation in impaired human leucine catabolism.
    Schriever SC; Deutsch MJ; Adamski J; Roscher AA; Ensenauer R
    J Nutr Biochem; 2013 May; 24(5):824-31. PubMed ID: 22898570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.
    Milkereit R; Persaud A; Vanoaica L; Guetg A; Verrey F; Rotin D
    Nat Commun; 2015 May; 6():7250. PubMed ID: 25998567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glutamine transport to suppress melanoma cell growth.
    Wang Q; Beaumont KA; Otte NJ; Font J; Bailey CG; van Geldermalsen M; Sharp DM; Tiffen JC; Ryan RM; Jormakka M; Haass NK; Rasko JE; Holst J
    Int J Cancer; 2014 Sep; 135(5):1060-71. PubMed ID: 24531984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
    Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
    Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the plasma amino acid profile by leucine via the system L amino acid transporter.
    Zhen H; Nakamura K; Kitaura Y; Kadota Y; Ishikawa T; Kondo Y; Xu M; Shimomura Y
    Biosci Biotechnol Biochem; 2015; 79(12):2057-62. PubMed ID: 26125295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone and Insulin-like growth factor-I (IGF-I) modulate the expression of L-type amino acid transporters in the muscles of spontaneous dwarf rats and L6 and C2C12 myocytes.
    Sawa R; Nishida H; Yamamoto Y; Wake I; Kai N; Kikkawa U; Okimura Y
    Growth Horm IGF Res; 2018; 42-43():66-73. PubMed ID: 30273774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAD-A kinase controls islet β-cell size and function as a mediator of mTORC1 signaling.
    Nie J; Liu X; Lilley BN; Zhang H; Pan YA; Kimball SR; Zhang J; Zhang W; Wang L; Jefferson LS; Sanes JR; Han X; Shi Y
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13857-62. PubMed ID: 23922392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.
    Ohshima Y; Kaira K; Yamaguchi A; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Yokobori T; Miyazaki T; Asao T; Tsushima Y; Kuwano H; Ishioka NS
    Cancer Sci; 2016 Oct; 107(10):1499-1505. PubMed ID: 27465934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: role in cell growth.
    Liu XM; Reyna SV; Ensenat D; Peyton KJ; Wang H; Schafer AI; Durante W
    FASEB J; 2004 Apr; 18(6):768-70. PubMed ID: 14977877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of branched-chain amino acid ratio on the proliferation, differentiation, and expression levels of key regulators involved in protein metabolism of myocytes.
    Duan Y; Zeng L; Li F; Wang W; Li Y; Guo Q; Ji Y; Tan B; Yin Y
    Nutrition; 2017 Apr; 36():8-16. PubMed ID: 28336113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.
    Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JE; Holst J
    J Natl Cancer Inst; 2013 Oct; 105(19):1463-73. PubMed ID: 24052624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the mammalian target of rapamycin (mTOR) complexes in pancreatic β-cell mass regulation.
    Bartolome A; Guillén C
    Vitam Horm; 2014; 95():425-69. PubMed ID: 24559928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal Diabetes Leads to Adaptation in Embryonic Amino Acid Metabolism during Early Pregnancy.
    Gürke J; Hirche F; Thieme R; Haucke E; Schindler M; Stangl GI; Fischer B; Navarrete Santos A
    PLoS One; 2015; 10(5):e0127465. PubMed ID: 26020623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1).
    Kongpracha P; Nagamori S; Wiriyasermkul P; Tanaka Y; Kaneda K; Okuda S; Ohgaki R; Kanai Y
    J Pharmacol Sci; 2017 Feb; 133(2):96-102. PubMed ID: 28242177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 variant inhibits insulin secretion in pancreatic β cells by attenuating LAT1-mediated amino acid uptake.
    Kobayashi N; Okazaki S; Sampetrean O; Irie J; Itoh H; Saya H
    Sci Rep; 2018 Feb; 8(1):2785. PubMed ID: 29434323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoisocaproic acid, a metabolite of leucine, suppresses insulin-stimulated glucose transport in skeletal muscle cells in a BCAT2-dependent manner.
    Moghei M; Tavajohi-Fini P; Beatty B; Adegoke OA
    Am J Physiol Cell Physiol; 2016 Sep; 311(3):C518-27. PubMed ID: 27488662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.